A unique technology—a breakthrough discovery—and Molecular Biologicals has transformed the way wounds and skin diseases are treated. Through extensive research and development, we have created Replicine™ Bioactive Keratin, a revolutionary technology that captures the native form and function of keratin proteins, thereby preserving their bioactivity. From acute wounds, such as burns, to chronic wounds caused by skin diseases like Epidermolysis Bullosa (EB), this proprietary technology has demonstrated the ability to activate keratinocytes, promote epithelialization, and enhance production of important basal membrane proteins.
This is where healing begins.
Our Mission is to explore the therapeutic benefits of the keratin molecule—as it is the foundation of organic tissue repair—and provide our products to those who are in greatest need.
Our Passions are keratin proteins and peptides, of which we currently manufacture proprietary fractionations that are incorporated into our prescription-only products.
Based on an extensive international research program and a strong evidence base of efficacy, Molecular Biologicals has developed 3 prescription-only wound healing products that deliver Replicine™ Bioactive Keratin technology directly to the wound to manage a broad range of wound types. Keragel® and KeragelT® are keratin-rich hydrogels. Keramatrix® is an absorbable matrix dressing enriched with keratin protein. Like countless others have throughout the world, discover the healing therapeutic benefits of keratin proteins and peptides.
What makes our keratin product so different from other keratin-based products? The answer lies in our proprietary Replicine™ Bioactive Keratin manufacturing process. This entails carefully extracting the keratin protein from sheep’s wool fully intact, thereby maintaining the form and function of the protein as well as its bioactivity—the main factor needed for healing.